• Complex
  • Title
  • Author
  • Keyword
  • Abstract
  • Scholars
Search

Author:

Chen, Ze-Tan (Chen, Ze-Tan.) | Li, Ling (Li, Ling.) | Guo, Ya (Guo, Ya.) | Qu, Song (Qu, Song.) | Zhao, Wei (Zhao, Wei.) | Chen, Hao (Chen, Hao.) | Su, Fang (Su, Fang.) | Yin, Jun (Yin, Jun.) | Mo, Qi-Yan (Mo, Qi-Yan.) | Zhu, Xiao-Dong (Zhu, Xiao-Dong.)

Indexed by:

SCIE PubMed Scopus

Abstract:

Radioresistance is the major cause of poor prognosis in nasopharyngeal carcinoma (NPC). To identify and characterize the secretome associated with NPC radioresistance, we compared the conditioned serum-free medium of radioresistant CNE-2R cells with that of the parental radiosensitive CNE-2 cells using isobaric tags for relative and absolute quantitation (iTRAQ) with liquid chromatography-electrospray tandem mass spectrometry (LC-ESI-MS/MS) quantitative proteomics. Before proceeding to quantitative proteomics, we investigated the survival curves of CNE-2R and CNE-2 cells by colony formation assay, and the CNE-2R survival curves were significantly higher than those for CNE-2. In total, 3,581 proteins were identified in the quantitative proteomics experiments, and 40 proteins exhibited significant differences between the CNE-2R and CNE-2 cells. Twenty-six of the 40 proteins were secreted by classical, non-classical, or exosomal secretion pathways. To verify the reliability of iTRAQ quantitative proteomics, we applied western blotting (WB) to study the secretory protein expression of fibrillin-2, CD166, sulfhydryl oxidase 1 and cofilin-2, which are involved in cell adhesion, migration and invasion. The WB results showed that fibrillin-2 (p=0.017) and sulfhydryl oxidase 1 (p=0.000) were highly expressed in the CNE-2 cells, while CD166 (p=0.012) and cofilin-2 (p=0.003) were highly expressed in the CNE-2R cells, which was in accordance with iTRAQ quantitative proteomics. Finally, a phenotypic subset of CD166-positive NPC cells was verified by immunocytochemistry. In summary, we defined a collection of secretory proteins that may be relevant to the radioresistance in NPC cells, and we determined that CD166, which is widely used as a positive marker of cancer stem cells, is expressed in NPC cells.

Keyword:

cancer stem cells CD166 cofilin-2 fibrillin-2 nasopharyngeal carcinoma secretome

Author Community:

  • [ 1 ] [Chen, Ze-Tan; Li, Ling; Qu, Song; Zhao, Wei; Chen, Hao; Su, Fang; Yin, Jun; Mo, Qi-Yan; Zhu, Xiao-Dong] Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 2 ] [Chen, Ze-Tan; Li, Ling; Qu, Song; Zhao, Wei; Chen, Hao; Su, Fang; Yin, Jun; Mo, Qi-Yan; Zhu, Xiao-Dong] Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 3 ] [Chen, Ze-Tan; Li, Ling; Qu, Song; Zhao, Wei; Chen, Hao; Su, Fang; Yin, Jun; Mo, Qi-Yan; Zhu, Xiao-Dong] Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 4 ] [Guo, Ya] Xi An Jiao Tong Univ, Dept Radiat Oncol, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China
  • [ 5 ] [Chen, Ze-Tan]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 6 ] [Li, Ling]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 7 ] [Qu, Song]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 8 ] [Zhao, Wei]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 9 ] [Chen, Hao]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 10 ] [Su, Fang]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 11 ] [Yin, Jun]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 12 ] [Mo, Qi-Yan]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 13 ] [Zhu, Xiao-Dong]Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi, Peoples R China
  • [ 14 ] [Chen, Ze-Tan]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 15 ] [Li, Ling]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 16 ] [Qu, Song]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 17 ] [Zhao, Wei]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 18 ] [Chen, Hao]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 19 ] [Su, Fang]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 20 ] [Yin, Jun]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 21 ] [Mo, Qi-Yan]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 22 ] [Zhu, Xiao-Dong]Guangxi Med Univ, Canc Inst Guangxi Zhuang Autonomous Reg, Nanning 530021, Guangxi, Peoples R China
  • [ 23 ] [Chen, Ze-Tan]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 24 ] [Li, Ling]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 25 ] [Qu, Song]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 26 ] [Zhao, Wei]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 27 ] [Chen, Hao]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 28 ] [Su, Fang]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 29 ] [Yin, Jun]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 30 ] [Mo, Qi-Yan]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 31 ] [Zhu, Xiao-Dong]Guangxi Med Univ, Key Lab High IncidenceTumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China
  • [ 32 ] [Guo, Ya]Xi An Jiao Tong Univ, Dept Radiat Oncol, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China

Reprint Author's Address:

  • Guangxi Med Univ, Dept Radiat Oncol, Canc Hosp, 71 He Di Rd, Nanning, Guangxi, Peoples R China.

Show more details

Related Keywords:

Source :

ONCOLOGY REPORTS

ISSN: 1021-335X

Year: 2015

Issue: 5

Volume: 34

Page: 2477-2488

2 . 4 8 6

JCR@2015

3 . 9 0 6

JCR@2020

ESI Discipline: CLINICAL MEDICINE;

ESI HC Threshold:178

JCR Journal Grade:3

CAS Journal Grade:4

Cited Count:

WoS CC Cited Count: 12

SCOPUS Cited Count: 12

ESI Highly Cited Papers on the List: 0 Unfold All

WanFang Cited Count:

Chinese Cited Count:

30 Days PV: 1

FAQ| About| Online/Total:932/172612388
Address:XI'AN JIAOTONG UNIVERSITY LIBRARY(No.28, Xianning West Road, Xi'an, Shaanxi Post Code:710049) Contact Us:029-82667865
Copyright:XI'AN JIAOTONG UNIVERSITY LIBRARY Technical Support:Beijing Aegean Software Co., Ltd.